antibody-drug conjugates

Trastuzumab Deruxtecan Improves Survival for Patients with HER2-Positive Metastatic Breast Cancer

Trastuzumab Deruxtecan Improves Survival for Patients with HER2-Positive Metastatic Breast Cancer

13 May 2023

2 min read

image-fallback

Pfizer Looks Past COVID With $43 Billion Deal For Cancer Drug Innovator Seagen

14 Mar 2023

2 min read

Medbound

www.medboundtimes.com